HaEmek EMLA 5% Cream Tinnitus Study
Also known as: Treating Tinnitus Using Eutectic Mixture of Local Anesthetics (EMLA) 5% Cream, EMLA 5% as a Treatment for Tinnitus and Its Accompanied Symptoms, EMLA cream 5%, Lidocaine/prilocaine cream tinnitus study, Cetomacrogol cream comparator, NCT02266160, 0055-14
Institution-led study
Academic randomized double-blind Phase 4 study testing topical EMLA 5% cream, a lidocaine/prilocaine local anesthetic combination, applied post-auricularly for tinnitus symptoms versus cetomacrogol sham lotion. Cetomacrogol is the inactive comparator, not a separate tinnitus pipeline program.
Verified from ClinicalTrials.gov as a completed HaEmek Medical Center Phase 4 study of post-auricular EMLA 5% cream versus sham cream for tinnitus symptoms. It is a historical institution-led study, not an FDA-regulated tinnitus product program.